Long-term statin therapy improves oncological outcome after radical gastrectomy for stage II and III gastric cancer

Anticancer Research

Volumn 34, Issue 1, 2014, Pages 355-361

  Nam, Dong Hyuk ^a   Lee, Hyuk ^a   Park, Jun Chul ^a   Shin, Sung Kwan ^a   Lee, Sang Kil ^a   Hyung, Woo Jin ^a   Lee, Yong Chan ^a   Kang, Min Woong ^a   Noh, Sung Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Gastric cancer; Radical gastrectomy; Statin therapy

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CASE CONTROL STUDY; CONTROLLED STUDY; DEATH; DRUG USE; FEMALE; FOLLOW UP; GASTRECTOMY; HAZARD RATIO; HUMAN; LONG TERM CARE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RADICAL GASTRECTOMY; RECURRENCE FREE SURVIVAL; SHORT COURSE THERAPY; STOMACH CANCER; TREATMENT DURATION; TREATMENT OUTCOME; ADENOCARCINOMA; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; STATIN THERAPY; STOMACH TUMOR; SURVIVAL RATE;

GASTRIC CANCER; RADICAL GASTRECTOMY; STATIN THERAPY;

ADENOCARCINOMA; AGED; CARCINOMA, SIGNET RING CELL; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84897026847     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R and Cholesterol Treatment Trialists C: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366(9493): 1267-1278, 2005.
2. Hebert PR, Gaziano JM, Chan KS and Hennekens CH: Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 278(4): 313-321, 1997.
3. Casey PJ: Protein lipidation in cell signaling. Science 268(5208): 221-225, 1995.
4. Goldstein JL and Brown MS: Regulation of the mevalonate pathway. Nature 343(6257): 425-430, 1990.
5. El-Serag HB, Johnson ML, Hachem C and Morgana RO: Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology 136(5): 1601-1608, 2009.
6. Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK and Rennert G: Statins and the risk of colorectal cancer. N Engl J Med 352(21): 2184-2192, 2005.
7. Bardou M, Barkun A and Martel M: Effect of statin therapy on colorectal cancer. Gut 59(11): 1572-1585, 2010.
8. Singh S, Singh PP, Singh AG, Murad MH and Sanchez W: Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis. Gastroenterology 144(2): 323-32, 2012.
9. Kastelein F, Spaander MC, Biermann K, Steyerberg EW, Kuipers EJ, Bruno MJ and Probar-study G: Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Gastroenterology 141(6): 2000-2008; quiz e2013-2004, 2011.
10. Chiu HF, Ho SC, Chen CC and Yang CY: Statin use and the risk of liver cancer: A population-based case-control study. Am J Gastroenterol 106(5): 894-898, 2011.
11. Singh H, Mahmud SM, Turner D, Xue L, Demers AA and Bernstein CN: Long-term use of statins and risk of colorectal cancer: A population-based study. Am J Gastroenterol 104(12): 3015-3023, 2009.
12. Siddiqui AA, Nazario H, Mahgoub A, Pandove S, Cipher D and Spechler SJ: The long-term use of statins is associated with a decreased incidence of adenomatous colon polyps. Digestion 79(1): 17-22, 2009.
13. Bababeygy SR, Polevaya NV, Youssef S, Sun A, Xiong A, Prugpichailers T, Veeravagu A, Hou LC, Steinman L and Tse V: HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model. Anticancer Res 29(12): 4901-4908, 2009.
14. Eaton M, Eklof J, Beal JR and Sahmoun AE: Statins and breast cancer in postmenopausal women without hormone therapy. Anticancer Res 29(12): 5143-5148, 2009.
15. Bonovas S, Filioussi K, Tsavaris N and Sitaras NM: Statins and cancer risk: A literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials. J Clin Oncol 24(30): 4808-4817, 2006.
16. Browning DR and Martin RM: Statins and risk of cancer: a systematic review and metaanalysis. Int J Cancer 120(4): 833-843, 2007.
17. Coogan PF, Rosenberg L and Strom BL: Statin use and the risk of 10 cancers. Epidemiology 18(2): 213-219, 2007.
18. Dale KM, Coleman CI, Henyan NN, Kluger J and White CM: Statins and cancer risk: A meta-analysis. JAMA 295(1): 74-80, 2006.
19. Bonovas S, Filioussi K and Sitaras NM: Statins are not associated with a reduced risk of pancreatic cancer at the population level, when taken at low doses for managing hypercholesterolemia: Evidence from a meta-analysis of 12 studies. Am J Gastroenterol 103(10): 2646-2651, 2008.
20. Graaf MR, Beiderbeck AB, Egberts AC, Richel DJ and Guchelaar HJ: The risk of cancer in users of statins. J Clin Oncol 22(12): 2388-2394, 2004.
21. Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, Wahlbeck K and Tiihonen J: Incidence of cancer and statin usage-record linkage study. Int J Cancer 126(1): 279-284, 2010.
22. Kaye JA and Jick H: Statin use and cancer risk in the General Practice Research Database. Br J Cancer 90(3): 635-637, 2004.
23. Chiu HF, Ho SC, Chang CC, Wu TN and Yang CY: Statins are associated with a reduced risk of gastric cancer: A population based case-control study. Am J Gastroenterol 106(12): 2098-2103, 2011.
24. Friis S, Poulsen AH, Johnsen SP, McLaughlin JK, Fryzek JP, Dalton SO, Sorensen HT and Olsen JH: Cancer risk among statin users: A population-based cohort study. Int J Cancer 114(4): 643-647, 2005.
25. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG and M. M: AJCC cancer staging manual - Sixth Edition: 99-106, 2002.
26. Japanese Gastric Cancer A: Japanese Classification of Gastric Carcinoma - Second English Edition. Gastric Cancer 1(1): 10-24, 1998.
27. Sarfati D: Review of methods used to measure comorbidity in cancer populations: No gold standard exists. J Clin Epidemiol 65(9): 924-933, 2012.
28. Muller C, Bockhorn AG, Klusmeier S, Kiehl M, Roeder C, Kalthoff H and Koch OM: Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-RAS oncogene but has different effects on protein phosphorylation and induction of apoptosis. Int J Oncol 12(3): 717-723, 1998.
29. Sata M: Biphasic effects of statins on angiogenesis. Circulation 106(11): e47; author reply e47, 2002.
30. Kusama T, Mukai M, Iwasaki T, Tatsuta M, Matsumoto Y, Akedo H, Inoue M and Nakamura H: 3-Hydroxy-3-methylglutarylco-enzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. Gastroenterology 122(2): 308-317, 2002.
31. Ng K, Ogino S, Meyerhardt JA, Chan JA, Chan AT, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Benson AB, 3rd, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Bertagnolli MM, Venook AP and Fuchs CS: Relationship between statin use and colon cancer recurrence and survival: Results from CALGB 89803. J Natl Cancer Inst 103(20): 1540-1551, 2011.
32. Park JM, Ryu WS, Kim JH, Park SS, Kim SJ, Kim CS and Mok YJ: Prognostic factors for advanced gastric cancer: Stage-stratified analysis of patients who underwent curative resection. Cancer Res Treat 38(1): 13-18, 2006.
33. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A and Italian Research Group for Gastric C: Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90(9): 1113-1119, 2003.
34. Yoo CH, Noh SH, Shin DW, Choi SH and Min JS: Recurrence following curative resection for gastric carcinoma. Br J Surg 87(2): 236-242, 2000.
35. Wang CY, Lin YS, Tzao C, Lee HC, Huang MH, Hsu WH and Hsu HS: Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection. Eur J Cardiothorac Surg 32(6): 877-881, 2007.
36. de Groot V, Beckerman H, Lankhorst GJ and Bouter LM: How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 56(3): 221-229, 2003.
37. Hawk E and Viner JL: Statins and cancer-beyond the 'one drug, one disease' model. N Engl J Med 352(21): 2238-2239, 2005.